Navigation Links
Global One Consulting Announces Exclusive Contract to Expand Saigene Biotech, Inc. Sales in Emerging Markets
Date:7/22/2009

PORTLAND, Ore., July 22 /PRNewswire/ -- Global One Principal Irl M. Davis today announced a relationship with Saigene Biotech, Inc. for the introduction and sale of a new class of harmful algae bloom detection technology in ASEAN nations, China, and Bangladesh. Global One, a consulting resource with thirty years of experience in China and other Asian nations, specializes in helping emerging products and technologies find their place in the global market. "Saigene's groundbreaking new assay technologies represent a significant advancement in early detection of the HAB microorganisms that undermine health and commerce throughout the world," said Davis.

Saigene's Universal Assay System is a patented method that includes a Universal Assay Processor and assay kits that are ready for the addition of sea water and fresh water samples. It is currently being used by major research and commercial entities worldwide. The Saigene assay enables automated, walk-away testing that is highly sensitive and able to quickly detect the presence of algal cells, even when they are not detectable under a microscope. Algae, the most abundant photosynthetic organism in marine and freshwater ecosystems, can damage vegetation, coral reefs, fish and wildlife, and water quality when it "blooms" excessively. Human exposure to algae-induced water toxins can cause neurological impairment, gastrointestinal upset or respiratory irritation, sometimes resulting in severe illness or death.

"The incidence of harmful algae blooms is rapidly increasing, both in number of blooms and in geographic spread," said Davis. "Early warning can help water quality agencies to prepare and alert affected populations and businesses before the HAB destroys health and well being."

"Our relationship with Global One reflects Saigene's commitment to wider adoption of assay technology to safeguard waterways from in
'/>"/>

SOURCE Global One
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. KTA Capital Advises SpringTree Global Investors on an AU$25.5 Million Investment in Prima BioMed Ltd
2. TorreyPines Receives Notice of Delisting from Nasdaq Global Market
3. Health Robotics Expands and Diversifies Global Channel Strategies With Joint-Ventures & Direct Operations
4. Stem Cell Cord Blood Banking Is Huge Global Business for Hospitals, Says CEO of Bio-Matrix Scientific Group Inc.
5. Covance Appoints Dr. Steven M. Michael as Vice President and Chief Scientific Officer of Global Bioanalytical Services
6. Global Small Molecule Kinase Inhibitors Market to Reach $16.2 Billion by 2015, According to a New Report by Global Industry Analysts, Inc.
7. Global Prescription Drugs Market to Cross $897 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
8. Cell Therapeutics Added to Russell 3000(R), Russell 2000(R) and Russell Global(R) Indexes
9. BioStorage Technologies, Inc., Appoints Jeff Goddard to Global Head of Sales
10. Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market
11. deCODE Reinstated to Nasdaq Global Market

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009).../PRNewswire-Asia/ -- Sinovac Biotech Ltd. ( SVA),...unced today that it executed,a joint venture (JV) ...chnology Co., Ltd. (Sinovac Dalian). The JV will r...use vaccines. Sinovac will contribute its expertis... world-class vaccines; the,other party will bring ...
(Date:11/24/2009)...also Visit Detroit , (Voc...ench Ambassador for International Investment, and ... , , ,What: Ambassador Appia is available to meet...ives adopted by France to further develop the fina...n and development., , ,When: Available for Intervi...
(Date:11/24/2009)...swire-FirstCall/ -- Sigma-Aldrich Corporation (Nas...conference on Tuesday, December 1st at 1:45 PM GMT... listen via live audio broadcast over the Internet...ldrich.com/ . Users can click the "Webcast" icon...h: Sigma-Aldrich is a leading Life Science and H...
(Date:11/24/2009)...PRNewswire-Asia/ -- Shanghai Biolaxy announced the...A) has approved the,investigational new drug appli..., an innovative insulin formulation to treat diabe...its first phase I clinical study. , Diabe...cose and poor,metabolism. The complications of dia...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Biolaxy Secures IND Approval for Oral Insulin 2
...AMIR, Israel, Jan. 14 Shamir,Optical Industry Ltd...of,innovative products and technology to the progr...t its board of directors had declared a dividend,d...ion (approximately NIS,15.1 million based on the J...or approximately US$ 0.243 (approximately NIS 0.91...
...nd HAIKOU, China, Jan. 14 /Xinhua-PRNewswire-First...a,) (OTC Bulletin Board: CPHI),which develops, man...aceutical products in China, today announced that ...itiate a proactive and targeted investor,relations...I, and their,collective team, will be advising the...
...an. 14 Today, The Woodbridge Group announced,the ...industry,s highest,levels of "Green" Polyurethane ...e strategy, BioFoam, a patented technology, substi...ing of polyurethane products. This,earth-friendly ...,applications includes; seat cushions, seat fabric...
Other Biology Technology:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program 2China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program 3Woodbridge Offers the Broadest Range of BioFoam(TM) 'Green' Polyurethane Automotive Interior Applications 2
(Date:11/26/2009)...cus Aureus ) and other drug-resistant bacteria cou...totype devices have been developed to offer safe, ..., Two prototype devices have been developed: one...hands and feet) in hospitals and public spaces whe...to shoot bacteria-killing agents into infested chr...
(Date:11/25/2009)...ath Research Laboratory in the University of Haifa...stigious Johnson & Johnson Focused Funding grant f...damage in Parkinson,s disease. The award, which is...ovation and excellence in science, was announced i...h at an event at the Hyatt Regency Hotel in New Je...
(Date:11/24/2009)...ribed by traditional healers in Brazil to treat a ...to fever and flu. , Now for the first time, resea...cientifically prove the pain relieving properties ...mint. , Testing this ancient South American herb ... was able to show that when prepared as a ,tea, t...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Got a pain? -- Have a cup of Brazilian mint 2Celebrate June Is Dairy Month Beginning With Breakfast 48128 1Celebrate June Is Dairy Month Beginning With Breakfast 48128 2Windows XP Vista and Windows 7 Compatible Remote Control 4 0 Beta Released by IntelliAdmin LLC 48124 1Windows XP Vista and Windows 7 Compatible Remote Control 4 0 Beta Released by IntelliAdmin LLC 48124 2Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 1Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 2Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 3Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 4Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 5Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 6Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 7Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 8
... variations ensure that no two people are exactly .... Now, researchers have the tools and the knowled... cancer therapies, enabling them to create more ef...ized medicine. At the 2007 Annual Meeting of the A...rs present new biomarkers ?and techniques for dete...
...by" hysteria of the 1980s was greatly exaggerated,... disabling cognitive impairments -- attention defi.... , A recent study by investigators at the Vander...ent may help explain the long-term behavioral and ...osure to cocaine. In a recent issue of the Journal...
...e that nanoparticles, engineered materials about a...d lead to cancer, according to research presented ...tion for Cancer Research. , Nanoparticles are smal... yet they are large enough to cause trouble by int...t the University of Massachusetts say. Such nanop...
Other Biology News:Genes and biomarkers that allow doctors to choose the right therapy for the right patient 2Genes and biomarkers that allow doctors to choose the right therapy for the right patient 3Genes and biomarkers that allow doctors to choose the right therapy for the right patient 4Genes and biomarkers that allow doctors to choose the right therapy for the right patient 5Genes and biomarkers that allow doctors to choose the right therapy for the right patient 6Prenatal cocaine's lasting cellular effects 2Prenatal cocaine's lasting cellular effects 3Cancer tip -- Nanoparticles can damage DNA, increase cancer risk 2
...to Alpha unit with motorized heated lid and skirte...microarrays and chips. The four screw-down points ...sealing force of the motorized lid is set with sof...results. This interchangeable Moto Alpha unit func...
...e factor 15 (KLF15) KLF15 is a Cys2-His2 zinc fin...liver, kidneys, heart, and skeletal muscle. Acces...y produced in rabbits immunized with a synthetic p...th an internal ID of P03590 Reconstitution and St...
Affi-Prep Protein A Support, 25 ml from Bio-Rad
...ard is a new tuning and calibration standard for p...trometry. Accumix is a lyophilized 7-peptide stan...oth tuning and calibration of ion trap (i.e. Finni...ectrometers. Direct infusion of the Accumix pepti...
Biology Products: